DNA Sequencing Market Synopsis

DNA Sequencing Market Size Was Valued at USD 11.1 Billion in 2023, and is Projected to Reach USD 37.3 Billion by 2032, Growing at a CAGR of 14.4% From 2024-2032.

The DNA sequencing market comprises of the technologies, products, and service offerings that provide for the determination of the particular order of nucleotide bases in a DNA molecule. It encompasses virtually all the sequencing techniques such as the Sanger technique, another presently advanced technique, the next-generation sequencing technique. The market caters to several fields; Clinical diagnostics, tailored medicine, genomics, transcriptomics and epigenomics, Agriculture, genetics and breeding and crop improvement, forensic, and direct-to-consumer testing. Critical components of the molecular market include sequencing instruments, reagents, software for analyzing data, and lab services for sequencing. The development of various sequencing technologies has been instrumental in the expansion of the market on account of the efficiency and cost optimizations of the crucial genetic analysis procedures that enhance biological and medical science breakthroughs. As the need for more accurate, detailed and versatile genomic information in ever-growing spectrum of uses, DNA sequencing market remains on the rise, inviting capital and strategic actions from both, old guard and emerging players in the biotechnology and health care industries.

• On that account, the DNA sequencing market has registered growth and change at a fast pace due to improved technologies as well as expanded uses within numerous sectors. According to recent disclosed information, the market is cogently experiencing a strong increase in sectors that include clinical utility and research arenas. Market players are investing in technologies that may help them fine the art of sequencing with higher accuracy, lower costs, and optimizing the throughput hence making it viable across many fields, disease diagnosis especially in pharmacogenomics, cancer research, farming, genetics, and even forensic. There has been a remarkable growth of the global NGS market due to the commercialization of NGS technologies such as FastPlex and Spectrum that have assist researchers and clinicians analyze a vast volume of genetic data within the shortest time and at minimum cost.
• Various market trends also suggest that true solutions for a particular process are becoming multiproduct, complete-sequence systems, encompassing sample preparation, sequencing, and data analysis. Furthermore, the constant use of Social media /Internet has created a new consumer segment where Direct to Consumer Genetic Testing Services have filled the market’s gap thus increasing its growth. Concerns of data privacy, compliance and regulatory restrictions, and availability of talented personnel are some of the challenges, which persist and shape market dynamics, as well as major players’ strategies. In summary, the identified DNA sequencing market is still rapidly developing due to technological innovation and new interdisciplinary applications of DNA sequencing in healthcare, agriculture, biotechnology, and other fields in the modern world.

DNA Sequencing Market Trend Analysis

Increasing integration of artificial intelligence (AI) and machine learning (ML) algorithms

• Another interesting development in the DNA sequencing market is a shift toward the use of artificial intelligence (AI) and machine learning (ML) model incorporation into analytical data from sequence samples. Further, with increased uptake of NGS platforms, the volume and complexity of the genomic data being analyzed is a rapidly growing problem that requires the application of sophisticated computer algorithms to assist in the analysis. In the analysis process, other advanced systems such as AI and ML are solutions that can be used to avoid estimation problems, to define the genetic variants, to predict risks of certain diseases, and to counsel targeted treatment. This trend not only enhances the speed and quality of genomic investigation but also the range of opportunities in other fields such as the fairly popular field of precision medicine, oncology, and genetics. Larger organizations and research concerns continue to advance the usage of AI bioinformatics to actively realize the value proposition of the genomic data, further fueling advancement and maturation of the systems, enabling further commercial growth in the DNA sequencing market.

Development of portable or point-of-care sequencing devices

• The gap that is rapidly emerging in DNA sequencing market relates to the establishment of portable or point-of-care sequencing technologies. Several shot-based sequencing technologies are complex and large, mainly carried out in specific laboratories to amplify the sample, thus restricting access and timing. But at the same time there is increasing interest towards the decentralized sequencing that can be applied in clinic, in the areas with no access to laboratory, field use etc.
• Chimeric grillers should be viewed as a domestication device with the ability to change the healthcare as a whole due to the possibility to carry out quickly and directly genetic confirming. It could help diagnose patients early and make appropriate treatment recommendations concerning complicated disease conditions requiring intensive care like diseases of microbiological origin or cancer care among others. However, it is also possible that these devices can play a critical role in agriculture and environment, to monitor the difference in genetic of crops, disease sources, or any other samples at real-time.

DNA Sequencing Market Segment Analysis:

DNA Sequencing Market Segmented on the basis of product, technology and application.

By Product, Instruments segment is expected to dominate the market during the forecast period

• Instruments is also expected to emerge as largest DNA sequencing market within the ongoing forecast period for product categories. I highly agree with the statement because instruments are critical to the DNA sequencing domain and involve a set of advanced technologies used for the identification of the order of nucleotides. The reagents in this segment are NGS platforms, which offer ultrafast, high-throughput DNA sequencing and have had a transformative impact on sectors such as genomics research and molecular diagnostics. The dominance of the Instruments segment can be attributed to constant technological improvements in improving the sequencing speed, accuracy, and the ability to scale up these tools, thus fueling its use across fields such as the healthcare, farming, and forensic industries.
• The major movers meanwhile have not sat still, with new instruments being developed to cover sample preparation, sequencing, and data analysis; all of which are important aspects for providing more answers to genomic demands. As the DNA sequencing research and clinical application grows more complex around the globe, the Instruments segment is ensured to be the leader contender which can put a huge impact on the future growth and development of the DNA sequencing market.

By Application, Clinical Investigation segment expected to held the largest share

• It is projected that the Clinical Investigation segment would continue to have the largest market share in the DNA sequencing space because of the emphasis on the utilization of this technique in clinical settings and other aspects of healthcare delivery. Despite its relatively recent evolution, these techniques are regularly incorporated into clinics for the identification of genetic diseases and the assessment of response to therapies as well as for the tracking of diseases. The growth of knowledge in next-generation sequencing (NGS) has permitted encompassing genomic profiling to help recognize mutations, biomarkers, and/or therapeutic targets concerning different diseases including cancer, strange genetic disorders, and infective diseases. This application of DNA sequencing is as important for improving diagnostic accuracy as to contribute to the construction of complicated individualized treatment options and approaches based on the patients’ profile.
• Also, the usage of sequencing not only in clinics for epidemiological investigations, pharmacogenomics, and population genetics contributes to the segment as well. In light of the globally trending subject of personalized and evidenced-based medicine, the Clinical Investigation segment is expected to grow further and importantly spear-headed by the more and more requirement of genomic information to enhance patient outcome and health care organization.

DNA Sequencing Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

• Dynamics and Latest Trends of DNA Sequencing Market: Asia Pacific is expected to indicate the highest growth during the course of forecast period for the DNA sequencing market on the grounds of various factors. It is also vital to note that the economies of most nations in the region are rapidly growing, which implies that there is improved health care facilities and increased research institutions. The latest advancements in genomics research and clinical diagnostics have seen key players in Asia such as China, Japan, India, and South Korea emerging into the market and hence demanding the latest sequencers. In addition, there has been increased healthcare costs across the world, enhanced awareness of P4 medicine and more and more cases of genomics research and their application in diseases related research in the worldwide area.
• Also, the increasing costs involved in sequencing technologies, and the increasing number of key market players seeking to augment their operations in Asia Pacific is also driving the market growth. These companies are wisely entering into joint ventures with local Universities and institutions, and investing in research partnerships as the healthcare business in the region continues to grow. Additional drivers include government support towards precision medicine and genomics research coupled with favorable regulatory scenario that is encouraging market growth. Therefore, Asia Pacific is all poised to solidify its position among the global leaders in the DNA sequencing market owing to its burgeoning research capabilities, economic potential and growth in the healthcare industry shall steer the market future of DNA sequencing in varied applications.

Active Key Players in the DNA Sequencing Market

• 10x Genomics (USA)
• Agilent Technologies (USA)
• BGI Genomics (China)
• Bio-Rad Laboratories (USA)
• Genewiz (USA)
• Illumina (USA)
• Macrogen (South Korea)
• Natera (USA)
• Oxford Nanopore Technologies (UK)
• PacBio Asia Pacific (Singapore)
• Pacific Biosciences (USA)
• PerkinElmer (USA)
• Qiagen (Germany)
• Roche Sequencing Solutions (Switzerland)
• Thermo Fisher Scientific (USA), and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: DNA Sequencing Market by Product
 4.1 DNA Sequencing Market Snapshot and Growth Engine
 4.2 DNA Sequencing Market Overview
 4.3 Instruments
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Instruments: Geographic Segmentation Analysis
 4.4 Consumables
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Consumables: Geographic Segmentation Analysis
 4.5 Services
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Services: Geographic Segmentation Analysis

Chapter 5: DNA Sequencing Market by Technology
 5.1 DNA Sequencing Market Snapshot and Growth Engine
 5.2 DNA Sequencing Market Overview
 5.3 Third Generation DNA Sequencing
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Third Generation DNA Sequencing: Geographic Segmentation Analysis
 5.4 Next-Generation Sequencing
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Next-Generation Sequencing: Geographic Segmentation Analysis
 5.5 Sanger Sequencing
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Sanger Sequencing: Geographic Segmentation Analysis

Chapter 6: DNA Sequencing Market by Application
 6.1 DNA Sequencing Market Snapshot and Growth Engine
 6.2 DNA Sequencing Market Overview
 6.3 Clinical Investigation
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Clinical Investigation: Geographic Segmentation Analysis
 6.4 Oncology
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Oncology: Geographic Segmentation Analysis
 6.5 Forensics & Agrigenomics
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Forensics & Agrigenomics: Geographic Segmentation Analysis
 6.6 Reproductive Health
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Reproductive Health: Geographic Segmentation Analysis
 6.7 HLA Typing
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 HLA Typing: Geographic Segmentation Analysis
 6.8 Others
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Others: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 DNA Sequencing Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 10X GENOMICS (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 AGILENT TECHNOLOGIES (USA)
 7.4 BGI GENOMICS (CHINA)
 7.5 BIO-RAD LABORATORIES (USA)
 7.6 GENEWIZ (USA)
 7.7 ILLUMINA (USA)
 7.8 MACROGEN (SOUTH KOREA)
 7.9 NATERA (USA)
 7.10 OXFORD NANOPORE TECHNOLOGIES (UK)
 7.11 PACBIO ASIA PACIFIC (SINGAPORE)
 7.12 PACIFIC BIOSCIENCES (USA)
 7.13 PERKINELMER (USA)
 7.14 QIAGEN (GERMANY)
 7.15 ROCHE SEQUENCING SOLUTIONS (SWITZERLAND)
 7.16 THERMO FISHER SCIENTIFIC (USA)
 7.17 OTHER ACTIVE PLAYERS

Chapter 8: Global DNA Sequencing Market By Region
 8.1 Overview
 8.2. North America DNA Sequencing Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product
   8.2.4.1 Instruments
   8.2.4.2 Consumables
   8.2.4.3 Services
  8.2.5 Historic and Forecasted Market Size By Technology
   8.2.5.1 Third Generation DNA Sequencing
   8.2.5.2 Next-Generation Sequencing
   8.2.5.3 Sanger Sequencing
  8.2.6 Historic and Forecasted Market Size By Application
   8.2.6.1 Clinical Investigation
   8.2.6.2 Oncology
   8.2.6.3 Forensics & Agrigenomics
   8.2.6.4 Reproductive Health
   8.2.6.5 HLA Typing
   8.2.6.6 Others
  8.2.7 Historic and Forecast Market Size by Country
   8.2.7.1 US
   8.2.7.2 Canada
   8.2.7.3 Mexico
 8.3. Eastern Europe DNA Sequencing Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product
   8.3.4.1 Instruments
   8.3.4.2 Consumables
   8.3.4.3 Services
  8.3.5 Historic and Forecasted Market Size By Technology
   8.3.5.1 Third Generation DNA Sequencing
   8.3.5.2 Next-Generation Sequencing
   8.3.5.3 Sanger Sequencing
  8.3.6 Historic and Forecasted Market Size By Application
   8.3.6.1 Clinical Investigation
   8.3.6.2 Oncology
   8.3.6.3 Forensics & Agrigenomics
   8.3.6.4 Reproductive Health
   8.3.6.5 HLA Typing
   8.3.6.6 Others
  8.3.7 Historic and Forecast Market Size by Country
   8.3.7.1 Bulgaria
   8.3.7.2 The Czech Republic
   8.3.7.3 Hungary
   8.3.7.4 Poland
   8.3.7.5 Romania
   8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe DNA Sequencing Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product
   8.4.4.1 Instruments
   8.4.4.2 Consumables
   8.4.4.3 Services
  8.4.5 Historic and Forecasted Market Size By Technology
   8.4.5.1 Third Generation DNA Sequencing
   8.4.5.2 Next-Generation Sequencing
   8.4.5.3 Sanger Sequencing
  8.4.6 Historic and Forecasted Market Size By Application
   8.4.6.1 Clinical Investigation
   8.4.6.2 Oncology
   8.4.6.3 Forensics & Agrigenomics
   8.4.6.4 Reproductive Health
   8.4.6.5 HLA Typing
   8.4.6.6 Others
  8.4.7 Historic and Forecast Market Size by Country
   8.4.7.1 Germany
   8.4.7.2 UK
   8.4.7.3 France
   8.4.7.4 Netherlands
   8.4.7.5 Italy
   8.4.7.6 Russia
   8.4.7.7 Spain
   8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific DNA Sequencing Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product
   8.5.4.1 Instruments
   8.5.4.2 Consumables
   8.5.4.3 Services
  8.5.5 Historic and Forecasted Market Size By Technology
   8.5.5.1 Third Generation DNA Sequencing
   8.5.5.2 Next-Generation Sequencing
   8.5.5.3 Sanger Sequencing
  8.5.6 Historic and Forecasted Market Size By Application
   8.5.6.1 Clinical Investigation
   8.5.6.2 Oncology
   8.5.6.3 Forensics & Agrigenomics
   8.5.6.4 Reproductive Health
   8.5.6.5 HLA Typing
   8.5.6.6 Others
  8.5.7 Historic and Forecast Market Size by Country
   8.5.7.1 China
   8.5.7.2 India
   8.5.7.3 Japan
   8.5.7.4 South Korea
   8.5.7.5 Malaysia
   8.5.7.6 Thailand
   8.5.7.7 Vietnam
   8.5.7.8 The Philippines
   8.5.7.9 Australia
   8.5.7.10 New Zealand
   8.5.7.11 Rest of APAC
 8.6. Middle East & Africa DNA Sequencing Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product
   8.6.4.1 Instruments
   8.6.4.2 Consumables
   8.6.4.3 Services
  8.6.5 Historic and Forecasted Market Size By Technology
   8.6.5.1 Third Generation DNA Sequencing
   8.6.5.2 Next-Generation Sequencing
   8.6.5.3 Sanger Sequencing
  8.6.6 Historic and Forecasted Market Size By Application
   8.6.6.1 Clinical Investigation
   8.6.6.2 Oncology
   8.6.6.3 Forensics & Agrigenomics
   8.6.6.4 Reproductive Health
   8.6.6.5 HLA Typing
   8.6.6.6 Others
  8.6.7 Historic and Forecast Market Size by Country
   8.6.7.1 Turkey
   8.6.7.2 Bahrain
   8.6.7.3 Kuwait
   8.6.7.4 Saudi Arabia
   8.6.7.5 Qatar
   8.6.7.6 UAE
   8.6.7.7 Israel
   8.6.7.8 South Africa
 8.7. South America DNA Sequencing Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product
   8.7.4.1 Instruments
   8.7.4.2 Consumables
   8.7.4.3 Services
  8.7.5 Historic and Forecasted Market Size By Technology
   8.7.5.1 Third Generation DNA Sequencing
   8.7.5.2 Next-Generation Sequencing
   8.7.5.3 Sanger Sequencing
  8.7.6 Historic and Forecasted Market Size By Application
   8.7.6.1 Clinical Investigation
   8.7.6.2 Oncology
   8.7.6.3 Forensics & Agrigenomics
   8.7.6.4 Reproductive Health
   8.7.6.5 HLA Typing
   8.7.6.6 Others
  8.7.7 Historic and Forecast Market Size by Country
   8.7.7.1 Brazil
   8.7.7.2 Argentina
   8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research